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Abstract
Genes regulating Caenorhabditis elegans insulin/IGF signaling (IIS) have largely been identified on the basis of their
involvement in dauer development or longevity. A third IIS phenotype is the first larval stage (L1) diapause, which is also
influenced by asna-1, a regulator of DAF-28/insulin secretion. We reasoned that new regulators of IIS strength might be
identified in screens based on the L1 diapauseand the asna-1 phenotype.Eighty- six genes were selected for analysis by virtue
of their predicted interaction with ASNA-1 and screened for asna-1-like larval arrest. ykt-6, mrps-2, mrps-10 and mrpl-43 were
identified as genes which, when inactivated, caused larval arrest without any associated feeding defects. Several tests
indicated that IIS strength was weaker and that insulin secretion was defective in these animals. This study highlights the role
of the Golgi network and the mitochondria in insulin secretion and provides a new list of genes that modulate IIS in C. elegans.
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Introduction
The insulin/IGF signaling (IIS) pathway has been extensively
studied in C. elegans because it plays a central role in different
aspects of the life history of the animal. These roles include dauer
entry and exit, life span, innate immunity, heat and oxidative stress
responses, and associative learning [1]. Most of the regulators of
insulin signaling have largely been found either by looking for
genes which when inactivated cause defects in dauer formation or
in longevity. In recent years a role for IIS has been demonstrated
in the execution of the first larval stage (L1) larval diapause [2,3].
Larvae enter this diapause if they hatch into an environment that
lacks food. They can remain in this state for about two weeks and
resume growth when food is supplied again. A strong daf-2/insulin
receptor mutant or over expression of a daf-2 antagonist causes
worms to arrest in this state without loss in feeding ability. It is
noteworthy that mutations in most other genes affecting IIS
activity do not display this phenotype perhaps because sufficiently
strong alleles do not exist. For instance weaker daf-2 mutants form
dauers, are long lived and do not arrest as L1 larvae. [4,5].
The ATPase ASNA-1 is required for both growth and the L1
diapause. A strong reductionof asna-1activity by the use of injection
RNAi causes worms to arrest as L1 larvae, but with the ability to
resume growth if gene activity is restored. A weaker interference
with ASNA-1 function, by feeding RNAi, results in a slow growth
phenotypeand leadstoarrestat differentlarval stages.Finallyasna-1
mutants possessing maternal but not zygotic gene activity grow up
to become scrawny sterile adults. Notably, even though asna-1
larvae arrest growth in the presence of food, they do not have
feeding defects, suggesting a lack of coordination between growth
and nutrient availability. asna-1 promotes growth non-autonomous-
ly and mutants in the gene have severely reduced IIS activity. asna-1
mutants are defective in DAF-28/insulin secretion which is the
likely cause of its growth defect [6]. In some respects the asna-1
mutant phenotype resembles that of daf-2 mutants. However, while
daf-2 mutants form dauers at 25uC, asna-1 mutants only do so in
sensitizedgeneticbackgrounds.Thereforeasna-1would likely notbe
found in screens for mutants in dauer formation or longevity.
With the understanding of the asna-1 phenotype as it relates to the
IIS, we wished to ask whether new genes affecting IIS strength could
be found that, like asna-1, primarily had a larval growth phenotype
when they were inactivated. We attempted to find such potential
modulators of IIS by making a list of predicted interactors of ASNA-
1and its homologs in the budding yeast and fruit flies, and then by
screening these genes for asna-1-like growth defects and early larval
arrests after RNAi knockdown. Employing this strategy we have
identified genes for three proteins of the mitochondrial ribosome and
aGolgi-associatedv-SNAREasnewmodulatorsofIISandDAF-28/
insulin secretion. We show that knocking down activity of genes
encoding mitochondrial ribosomal proteins leads to decreased
mitochondrial membrane potential. This may in turn lead to
alterationsintheATP/ADPratio,whichisakeystimulatorofinsulin
secretion. In the case of ykt-6 its demonstrated role in Golgi function
is consistent with the notion that in insulin secretion may be reduced
because dense core vesicle biogenesis is affected in these animals.
Materials and Methods
C. elegans strains and maintenance
Worms were maintained under standard conditions [7] at 20uC
on NGM plates unless otherwise stated. N2 is the wild type parent
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34507for all the strains in the study. The mutants and transgenes used
were rrf-3 (pk1426), daf-7(e1372), daf-2(1370), daf-16(mgDf50),
svIs69 (pdaf-28::daf-28::gfp), zcIs13(phsp-6::gfp), arIs37(pmyo-3::ss::gfp),
zIs356(pdaf-16::daf-16::gfp) and dvIs19 (pgst-4::gfp::NLS). All the
mutants and transgenic strains are described in wormbase (www.
wormbase.org)
Plasmids
Feeding RNAi plasmids for mrps-10, mrpl-43 and mrrf-1 were
constructed by amplifying the entire genomic coding region and
cloning them into L4440 as BglII/NcoI fragments.
Feeding RNAi
All the bacterial clones expressing dsRNA for the RNAi
experiments, except for the ones described above, came from a
library that was purchased from the Ahringer lab [8]. Feeding
RNAi was performed as described [9]. The rrf-3 (pk1426) strain
was used for the RNAi experiments unless otherwise stated.
Pharyngeal pumping assay
RNAi against the genes that was tested for the assay was
performed as described above. The number of pharyngeal strokes
per 20 seconds of each such RNAi treated animal was counted
under a Leica MZFLIII dissecting microscope at 4006 magnifi-
cation. A graph of recordings was plotted using GraphPad Prism
version 5.0c (for Macintosh).
Fluorescent beads uptake assay
Fluoresbrites 0.2 mm fluorescent beads (Polysciences, Inc.) were
mixed with RNAi bacterial suspensions at a 1:50 dilution and
seeded onto RNAi plates incubated overnight. The RNAi against
the genes that were tested for the assay was performed as described
above. The worms thus obtained were incubated on the plates
containing beads for 2 hrs. Micrographs were taken using a Leica
DMRB microscope equipped with fluorescence optics at 636
magnification.
FM4-64 dye uptake assay
The RNAi affected worms were incubated in a solution of
0.4 mM FM4-64 dye (Molecular Probes) for 1 hr and the animals
were then transferred to M9 buffer and incubated for 1 hr.
Micrographs of the treated worms were taken using the
fluorescence microscope at 636magnification.
DAF-16::GFP assay
The rrf-3 (pk1426) was crossed into worms carrying the
integrated DAF-16::GFP (zIs356) transgene and used for the
studies. RNAi against the genes were performed as described in
feeding RNAi technique. The worms obtained after RNAi
treatment were micrographed using fluorescence microscope at
1006magnification.
Dauer phenotype enhancement studies
Experiments to check the enhancement of the Daf-c phenotype
of daf-7 (e1372ts) were done at 20uC and for the daf-2(e1370ts)
mutant they were done at 15uC. RNAi against each gene in both
mutants was performed at least two times. The number of
semidauers and dauers formed were counted and a graph was
plotted using GraphPad Prism version 5.0c. Dauer larvae were
tested for resistance to 1% SDS [10] by placing them in 200 uL of
the solution for 10 minutes at room temperature and then
transferring them to a seeded NGM plate to assess how many
worms were alive. No L3 stage (non-dauer) wild-type larvae,
exposed to the 1% SDS solution for 10 minutes in parallel,
survived this treatment.
phsp-6::GFP reporter assay
Worms carrying the integrated phsp-6::GFP reporter transgene
(zcIs13) were treated with feeding RNAi bacteria as described in
the feeding RNAi section. Micrographs were taken using the
fluorescence microscope at 636magnification.
TMRE staining
The arrested larvae arising from feeding RNAi against the
tested genes were stained with Tetramethylrhodamine, ethyl ester
(TMRE) dye [11]. For quantification of the staining, the images
from the fluorescence microscope were converted to grayscale and
the region of each worm from the beginning of the intestine to the
rectum was selected and used for pixel intensity measurements
using the ImageJ software.
Statistics
A mixed-effect model with Poisson errors was used to assess the
effects of the daf-16(mgDf50) mutation to growth of the seven
RNAi treatments. The proportion of individuals reaching above
stage L3 was considered as the response variable and addition of
the daf-16 mutation was considered as treatment. RNAi regimens
were fixed effects together with their interactions. The significance
level of wild type6treatment interaction was calculated using a
likelihood-ratio test. The mixed-effects model analysis was carried
out using the R 2.14.0 software [12].
Results
Identification of Genes that Promote Larval Development
Yeast two hybrid studies, co-immunoprecipitation studies and
genome-wide predictions have led to the identification of thirteen
genes that interact with C. elegans asna-1 [13,14], six genes that
interact with the Drosophila melanogaster homologue CG1598 [15]
and 77 genes that interact with the Saccharomyces cerevisiae
homologue Get3 [16,17,18]. This database of physical interactors
is compiled at http://thebiogrid.org. We identified C. elegans
homologues of the D. melanogaster and S. cerevisiae interactors using
BLASTp and SMART [19] sequence comparison tools. This
provided a list of 143 genes of which 86 were tested by feeding
RNAi (Table S1) in the RNAi hypersensitive mutant rrf-3(pk1426)
[20]. In the first stage of the screen we looked for RNAi clones that
did not allow the rrf-3 mutant worms to grow beyond the 3
rd larval
stage (L3) after 4 days and that produced larvae that were scrawny
and pale in appearance (Figure 1A and 1B). This phenotype is
similar to the feeding RNAi phenotype of asna-1 and represents a
weaker form of the strict L1 arrest phenotype that is produced only
with injection RNAi.
The genes identified in this manner were mrps-2/mitochondrial
ribosomal protein (T23B12.3), ykt-6/v-SNARE (B0361.10), goa-
1(C26C6.2), F41C3.4/Golgi transport 1 homolog, rps-0/cytoplasmic
ribosomal protein (B0393.1), iars-1/isoleucyl tRNA synthetase (R11A8.6),
enpl-1/GRP94 (T05E11.3), and tomm-40/translocase of outer mitochon-
drial membrane (C18E9.6). The feeding RNAi plasmids were
sequenced to ensure that they were correct. We have previously
reported a modulatory function for tomm-40 in IIS activity [21]
and the study of enpl-1 will be described elsewhere (B.N, P.N &
G.K in preparation). Analysis of the remaining six genes is
described below.
asna-1(RNAi) animals do not display a feeding defect or
developmental defects, despite having a growth delay phenotype
[6]. To determine which of the genes when knocked down showed
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animals for feeding defects or developmental abnormalities that
might cause growth arrest. Feeding ability was assayed by the
pharyngeal pumping rate, ability of worms to ingest bacterial-sized
beads and of their intestinal cells to take up luminal contents by
endocytosis. Knockdown of mrps-2, ykt-6, iars-1 and rps-0 had little
or no effect on pharyngeal pumping (Figure 2A), bead uptake
(Figure 2B), or internalization of the dye FM4-64 by intestinal cells
in affected animals (Figure 2C). By contrast, pharyngeal pumping
was much reduced in F41C3.4 (RNAi) and goa-1(RNAi) animals
(Figure 2A), which raised the possibility that these animals were
growth retarded because of starvation induced by pharyngeal
defects. Consequently these genes were not analyzed any further.
Knockdown of mrps-2, ykt-6, iars-1 and rps-0 did not produce
animals with any visible developmental or anatomical defects that
would explain the retarded growth. Consistently, the affected
animals resumed growth on normal bacteria, indicating that the
growth arrest was reversible and not due to catastrophic defects.
We next asked whether the phenotypes obtained by down-
regulation of mrps-2 could also be elicited by RNAi against genes
encoding two other mitochondrial ribosomal proteins, mrps-10
(Y37D8A.18) and mrpl-43 (C25A1.13), and an annotated mito-
chondrial ribosome recycling factor mrrf-1 (T20F5.3) (www.
wormbase.org). However, since mrrf-1 does not have a mitochon-
drial targeting sequence (Table S2) it may not function in the
mitochondria. A retarded growth phenotype was observed upon
inactivation of mrps-10 and mrpl-43, but not mrrf-1 (Figure 1A).
mrps-10(RNAi) and mrpl-43(RNAi) animals did not display any
defects in feeding ability (Figure 2A, 2B and 2C). Taken together
the results show that mrps-2, mrps-10, mrpl-43, ykt-6, iars-1 and rps-0
are required for larval growth but not for feeding and were
possible modulators of IIS.
Analysis of Insulin/Igf Activity in the Growth Defective
Animals
We next asked whether the reversible growth arrest in the
presence of food and in the absence of feeding defects was due to
defective IIS activity. To do this three well characterized assays
were used to examine the strength of the IIS pathway in vivo: First,
when IIS is weak, localization of the downstream transcription
factor DAF-16 is nuclear and not cytoplasmic. This is assayed by
using a functional daf-16::gfp reporter [22]. Second, the ability to
form dauers or semi-dauers under conditions that normally
prevent dauer formation indicates that the activity of the IIS or
TGFb pathways may be weak. If inactivation of a candidate gene
is synergistic for dauer formation with a weak TGFb pathway
mutation [23,24] but not with a weak insulin pathway mutation,
this would indicate that RNAi against the candidate gene likely
causes reduced IIS. Third, if the larval growth phenotype is caused
by weak IIS, then it should be suppressed in a daf-16 null mutant
Figure 1. Feeding RNAi analysis of the genes affecting C.
elegans larval development. A) Feeding RNAi against several genes,
but not mrrf-1, caused larval growth phenotypes. Gro: Growth arrest;
Lva: larval arrest; Clr: Clear body; WT: wild-type. Empty vector (L4440)
feeding RNAi was used as a control in all experiments. B) Fraction of
animals above stage L3 after RNAi treatments in one representative
experiment.
doi:10.1371/journal.pone.0034507.g001
Figure 2. Analysis of pharyngeal pumping, feeding and
endocytosis in RNAi treated animals. A) Quantification of
pharyngeal pumping rates after feeding RNAi. Each circle represents a
single animal. Error bars represent a 95% confidence interval of the
mean pumping rate. B) Overlay of differential interference contrast
microscopy (DIC) and fluorescence images of worms exposed to RNAi
against indicated genes and control RNAi to assay for their ability to
ingest fluorescent beads. Arrows indicate accumulation of beads in the
intestinal lumen. C) Fluorescence images of worms tested for uptake of
FM4-64 dye by intestinal cells after exposure to RNAi against indicated
genes and control RNAi.
doi:10.1371/journal.pone.0034507.g002
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pathway.
With the exception of iars-1, RNAi against all genes that
produced a nutrient insensitive retarded growth phenotype also
led to the nuclear localization DAF-16::GFP (Figure 3B). The
nuclear localization of DAF-16::GFP indicated that it was likely
that IIS strength might be lower in these animals. However several
other signaling pathways and metabolic conditions also alter the
localization of DAF-16::GFP, so this finding on its own suggested,
but did not confirm that IIS activity was reduced.
RNAi against mrps-2, mrps-10 and mrpl-43 in the RNAi
hypersensitive rrf-3 background led to production of a large
number of complete dauers that had all the dauer characteristics
[10], including elaboration of dauer alae (Figure 3C), dauer
specific constricted pharynges (Figure 3D) and SDS resistance of
the larvae. Specifically, 48/50 mrps-2(RNAi) dauers, 56/58 mrps-
10(RNAi) dauers, and 62/64 mrpl-43(RNAi) dauers were resistant
to 1% SDS. RNAi against mrps-2, mrps-10 and mrpl-43 in rrf-3(+)
animals did not lead to dauer larvae production, but this treatment
enhanced the temperature sensitive dauer constitutive (Daf-c)
phenotype of heat sensitive daf-7/TGFb mutant animals at 15uC.
However the same RNAi treatment did not enhance the Daf-c
phenotype of heat sensitive daf-2/insulin receptor mutants (Figure 3E).
This differential ability of the RNAi treatments to enhance
mutants in the TGF-b signaling pathway but not those in the IIS
pathway shows that mrps-2, mrps-10 and mrpl-43 down-regulation
likely modulates the IIS pathway. To investigate this notion
further we next tested whether growth was dependent on DAF-16
function.
DAF-16/FOXO is the most downstream component of the IIS
and it is negatively regulated by high IIS activity. Consequently
IIS is constitutively high in daf-16 null mutants [25]. We expected
that if growth arrest is due to low IIS activity upon knockdown of
the genes under study, this phenotype should be suppressed by the
high IIS activity in daf-16 mutants. We observed that the larval
growth phenotype of mrps-2, mrps-10, mrpl-43 and ykt-6 RNAi
knockdown worms was significantly suppressed in the strong daf-
16(mgDf50) mutant, while loss of daf-16 had no effect on the
growth phenotype of rps-0 and iars-1 knockdown animals
(Figure 3A). We have previously reported that tomm-40(RNAi) also
reduces IIS strength and produces a similar larval growth
phenotype due to defective IIS strength [21]. As a control, the
larval growth phenotype was examined in tomm-40(RNAi);daf-
16(mgDf50) animals. Here too the growth defect was significantly
suppressed. In all cases, RNAi was also performed in parallel in
wild-type animals where, as before, larval arrest was observed
Figure 3. Effect of depletion of gene function of identified
genes on insulin/IGF signaling. A) The growth defect by RNAi
against ykt-6, mrps-2, mrps-10, mrpl-43 and tomm-40 is suppressed in
daf-16 mutants. Bar plot showing mean growth rate coefficients
between wild-type and daf-16(mgDf50) animals after RNAi. 0 corre-
sponds to no difference in growth above stage L3 between daf-
16(mgDf50) mutants and wild-type animals. Positive values indicate
better growth in the daf-16 background, where 1 corresponds to a
twice as large fraction growing past stage L3 in RNAi treated daf-16
worms vs. RNAi treated wild-type worms. 2 corresponds to a three
times as large fraction growing past stage L3 etc. Error bars are +/2 SE
for two individual experiments. NS=not significant, *** P,0.001.
Significance levels were calculated using z-tests. B) Fluorescence
micrographs showing nuclear/cytoplasmic localization of DAF-16::GFP
after RNAi against indicated genes. Arrows indicate nuclei that
accumulate DAF-16::GFP. C) DIC micrographs showing dauer-specific
alae in dauer larvae with the indicated RNAi treatments. D) DIC
micrographs showing radially constricted pharynges in dauer larva with
the indicated RNAi treatments compared to a control larva in stage L3.
Arrows indicate outline the region between the two pharyngeal bulbs.
E) Quantification of dauer formation in animals with RNAi against the
indicated genes in wild-type, daf-2, rrf-3, and daf-7 mutants in two
experiments. Control (RNAi): N2(n=600), daf-2(n=220), rrf-3(n=660),
daf-7(n=655). mrps-2(RNAi): N2(n=600), daf-2(n=197), rrf-3(n=640),
daf-7(n=630). mrps-10(RNAi): N2(n=600), daf-2(n=202), rrf-3(n=920),
daf-7(n=600). mrpl-43(RNAi): N2(n=600), daf-2(n=189), rrf-3(n=730),
daf-7(n=615). mrrf-1(RNAi):N2(n=600), daf-2(n=189), rrf-3(n=980),
daf-7(n=753). The N numbers are the total of two experiments. Error
bars are +/2 SE for two individual experiments.
doi:10.1371/journal.pone.0034507.g003
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suppression was due to the daf-16 mutation.
Thus the growth arrest observed upon down-regulation of mrps-
2, mrps-10, mrpl-43 and ykt-6, but not that of iars-1 and rps-0
requires the activity of DAF-16. Taken together, our studies show
that mrps-2, mrps-10, mrpl-43 and ykt-6 positively modulate IIS
pathway activity and this modulation is dependent on DAF-16
function. Although rps-0 (RNAi) and iars-1 (RNAi) displayed a
strong growth arrest phenotype and rps-0 (RNAi) animals had
nuclear localized DAF-16::GFP, the larval arrests were not daf-16
dependent and knockdown animals did not form dauers or semi-
dauer larvae. These findings suggest that the larval growth
phenotype seen upon RNAi of iars-1 and rps-0 is not due to a
reduced IIS activity.
Low Insulin/IGF Signaling Activity Is Associated with
Mitochondrial Dysfunction
Three genes identified in the screen are predicted with high
confidence (Table S2) to be mitochondrial proteins. To under-
stand how they might affect IIS, we investigated whether RNAi
against these genes caused mitochondrial dysfunction. A mito-
chondrial specific stress response is evoked and phsp-6::gfp is
induced when the mitochondrial milieu is substantially degraded
[11]. phsp-6::gfp was induced after knockdown of mrps-2, mrps-10
and mrpl-43 genes, but not mrrf-1 (Figure 4A). Mitochondrial
dysfunction was also tested by assessing levels of the mitochondrial
proton gradient in animals stained with the dye TMRE [11]. mrps-
2, mrps-10 and mrpl-43 (RNAi) animals had reduced TMRE
staining in the intestinal region, while control and mrrf-1(RNAi)
had a consistent staining pattern throughout the animals
(Figure 4B). Quantification of the TMRE staining (Figure 4C)
shows that staining in mrps-2(RNAi), mrps-10(RNAi) and mrpl-
43(RNAi) animals were significantly different from that seen in the
control RNAi animals. This indicated that the proton gradient was
weaker in animals with knockdown of mrps-2, mrps-10 and mrpl-43
due to a diminished flow of electrons through the electron
transport chain, while this was not the case in mrrf-1(RNAi)
animals. The induction of mitochondrial stress appeared to be
specific because we did not detect any increase in oxidative stress
using the gst-4::gfp reporter in these animals (Figure S2). Taken
together, the results show that the RNAi treatment against mrps-2,
mrps-10 and mrpl-43 caused significant levels of mitochondrial
dysfunction and suggest that the weak IIS may be attributable to
this defect.
Insulin Secretion Is Defective in the Growth Defective
Animals
To understand the defects that are the basis for the apparent
lack of coupling between growth promotion and nutrient
availability, we assayed the ability of the knockdown worms to
secrete DAF-28/insulin by using a secretion competent DAF-
28::GFP reporter encoded by the svIs69 transgene. In all wild-type
animals DAF-28::GFP is secreted into the open circulatory system
(the pseudocoelum) and taken up by specialized cells residing there
called coelomocytes. Defective DAF-28::GFP secretion is quanti-
fied as the percentage of animals that have no GFP labeled
coelomocytes [6]. daf-28 is an agonist for the daf-2/insulin receptor
and is expressed at high levels only when food is abundant [26,27].
Secretion of a DAF-28::GFP reporter can be diminished under
conditions when worms perceive themselves as being starved [6].
DAF-28::GFP secretion was low in ykt-6, mrps-2, mrps-10 and mrpl-
43 knockdown animals (Figure 5A and 5B). Consistent with the
finding that iars-1, rps-0 and mrrf-1 do not influence IIS pathway
activity, secretion of DAF-28::GFP in animals was at or near wild-
type levels when these genes were inactivated (Figure 5A). The ykt-
6(RNAi) animals that did not secrete DAF-28::GFP normally
displayed a previously unreported DAF-28::GFP accumulation
pattern around the gonad (Figure 5C and Figure S1). This
accumulation of the reporter protein around the gonad has not
been seen in wild-type animals, or other strains that have defects in
DAF-28::GFP secretion.
The secretion defects observed here could be caused by a
general defect in secretion or a defect in the ability of the
coelomocytes to take up secreted proteins. To test if this was the
case, we examined the secretion and uptake of a secretion
competent GFP encoded by the body muscle expressed arIs37
transgene. If the GFP is not secreted it will remain in body muscles
and not accumulate in the coelomocytes. If coelomocyte function
is affected then the GFP will leave the body muscles, but
accumulate in the pseudocoelomic space and not the coelomo-
cytes. We observed that secreted GFP was taken up by
coelomocytes normally in these RNAi knockdown and control
animals (Figure 5D), indicating that coelomocytes are functional
and that these animals are secretion competent. We note that due
to limitations of the assay system the extent of defective DAF-
28::GFP secretion is likely an underestimate of the true extent of
the defect, as it can be tested only in adult worms.
Discussion
Here we report on a screen for new modulators of IIS by
analyzing eighty-six genes that encode predicted ASNA-1 inter-
actors and identifying which, upon knocked down, phenocopy the
asna-1 growth phenotype. It is important to note that besides its
role in IIS pathway activity, ASNA-1 has several other roles such
Figure 4. Analysis of mitochondrial function after RNAi against
mitochondrial ribosomal protein encoding genes. A) Fluores-
cence micrographs showing induction of phsp-6::GFP after RNAi against
the indicated genes. Five animals are displayed in each panel. B)
Fluorescence micrographs depicting TMRE staining in animals after
RNAi against the indicated genes. Five animals are displayed in each
panel. C) Mean TMRE fluorescence intensities relative to the control in
RNAi-treated animals. Control animals were fed with empty vector
L4440. Error bars represent a 95% confidence interval of the mean
fluorescence intensity. Significance levels were calculated by student’s
t-tests vs. control. *** P,0.0001 and * P=0.017.
doi:10.1371/journal.pone.0034507.g004
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metal resistance [30]. Our previous work shows that the IIS
activity of ASNA-1 can be genetically separated from its role in
metal resistance [31]. The yeast ASNA-1 homolog, Get3, also has
roles in G protein signaling and chloride channel function that
appear to be independent of its role in the biogenesis of tail-
anchored proteins [32,33]. However we note that for the purpose
of this study, this list of genes was used solely as a set of potential
modulators of IIS strength. It is possible that some of the genes in
this list could modulate other aspects of the ASNA-1 phenotype.
Orthologs of ASNA-1 are highly related across the phylogenetic
spectrum and the Homo sapiens ortholog can functionally replace
the C. elegans protein [6,31]. It was therefore likely that testing the
homologs of potential ASNA-1 interacting proteins from different
model systems could yield meaningful results. On the other hand if
ASNA-1 orthologs have acquired special functions in S. cerevisiae or
if the genetic interactions in a single celled organism have reduced
relevance for a metazoan such an approach can have limited
utility. It should be noted that although S. cerevisiae does not have
an insulin-like signaling pathway, its ASNA-1 ortholog GET3 is
responsive to nutritional conditions and plays a role in the
adaptation of the yeast cells to different nutritional conditions
[34,35].
Notwithstanding potential drawbacks, this approach was
successful in identifying four genes that act in the Golgi network
or the mitochondria, are essential for larval growth, are positive
modulators of insulin signaling and promote insulin secretion. The
screen was also successful in the opposite sense of being able to
eliminate potential candidates from further study because of the
conditions that were imposed. Two genes of the initial candidate
set (goa-1 and F41C3.4) whose RNAi phenotype resembled that of
asna-1, were eliminated because they had strong feeding defects
and two others (rps-0 and iars-1) were also eliminated from further
consideration because the larval growth arrest seen in the
knockdown animals was not daf-16 dependent. In rps-0(RNAi)
animals, DAF-16::GFP was nuclear localized, but since a daf-16
mutant did not suppress growth, the growth phenotype was likely
not solely due to lowered IIS.
Knockdown of the Golgi localized v-SNARE ykt-6 showed that
Golgi dysfunction was able to perturb insulin secretion ability. ykt-
6 depletion affects the levels of a Golgi resident protein, and
produces a larval arrest phenotype like the one we observed [36].
It is well established that mammalian insulin secretion requires
plasma membrane SNARE proteins to promote dense-core vesicle
(DCV) docking and release [37] . Here we show that a Golgi
SNARE protein also plays a role in insulin secretion. The Golgi
network is very elaborate in secretory cells and is the source of
secretory vesicles like the dense core vesicles.
DCV biogenesis starts with the active budding of this class of
vesicles from the trans-Golgi network (TGN) followed later by
acidification of the lumen and removal of mis-incorporated
proteins. Timely replenishment of spent DCVs is also in part
regulated at the level of TGN function [38]. It is possible that
dysfunction of the Golgi via inactivation of ykt-6 could lead to
downstream defects in the formation of secretory vesicles and
consequently in DAF-28/insulin secretion. The involvement of a
SNARE in worm insulin secretion taken together with previous
studies highlighting the importance of the dense-core vesicle
component UNC-31/CAPS [39] and the ATPase ASNA-1 in
worm insulin secretion shows that the secretion of DAF-28/insulin
is mechanistically similar to that of mammalian insulins. The
findings using DAF-28 as a model insulin therefore will have
general relevance.
At the levels of ykt-6 inactivation obtained under our
experimental conditions, the suppression of the larval growth
phenotype by daf-16 (Figure 3A), nuclear localization of DAF-
16::GFP (Figure 3B) and the inhibition of DAF-28::GFP secretion
(Figure 5A, 5B) with no effect on ss::GFP secretion (Figure 5D),
strongly supports the notion that down-regulation of ykt-6 leads to
defects in IIS strength. We note that suppression of the growth
defect of ykt-6(RNAi) animals by the daf-16(mgDf50) mutation is not
complete, likely reflecting the fact that the growth defect is not
solely due to down-regulation of IIS. The phenotype seen in ykt-6
(RNAi) animals is different from that seen upon RNAi against the
mitochondrial ribosomal encoding genes in that dauers or semi-
dauers were not seen in the progeny of ykt-6(RNAi) animals. One
reason for this difference may be that the growth defect imposed
by ykt-6(RNAi) prevents the affected larvae from reaching the
dauer commitment (L2D larva) stage. Another reason for the
Figure 5. Analysis of DAF-28::GFP and ss::GFP secretion. A)
Quantification of DAF-28::GFP secretion defects in control and
experimental RNAi worms. Error bars are +/2 SE for three individual
experiments. B) Paired DIC (top) and fluorescence (bottom) images of
daf-28::gfp expressing worms exposed to control RNAi (top) or ykt-
6(RNAi) (bottom). Arrows indicate coelomocytes. No DAF-28::GFP
accumulation is seen in the coelomocytes of the ykt-6(RNAi) animal
shown here. C) Paired DIC (left) and fluorescence (right) images of two
ykt-6(RNAi) worms that did not secrete daf-28::gfp. DAF-28::GFP protein
now accumulates around the gonad. n=intestinal nucleus. The
anterior/posterior axis is indicated. D) Overlay of DIC and fluorescence
images of worms with control RNAi and RNAi against indicated genes
to test for the secretion and uptake of ss::GFP. In all cases GFP
accumulates only in the coelomocytes (green cells).
doi:10.1371/journal.pone.0034507.g005
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by RNAi vary from gene to gene . To our knowledge this is the
first report of Golgi dysfunction causing a defect in IIS strength.
For both the Golgi localized v-SNARE protein YKT-6 [36] and
for the mitochondrial ribosomal proteins mrps-2, mrps-10 and mrpl-
43 the analysis presented here suggests that growth control was at
least partly due to a weaker insulin signaling. This reduction could
at least in part be explained as a result of lowered DAF-28/insulin
secretion. Since expression of the DAF-28::GFP appeared to be at
similar levels in control and experimental RNAi animals, these
results suggest that DAF-28 activity can be modulated at the level
of secretion which is consistent with previous work [6]. This result
reinforces the notion that in addition to the transcriptional
regulation of daf-28 [26], mechanisms regulating DAF-28 activity
at other levels remain to be discovered [21].
The reduced IIS activity after RNAi against mrps-2, mrps-10 and
mrpl-43 is likely due to mitochondrial dysfunction. Down-
regulation of these genes triggers mitochondrial stress response,
as measured by increased hsp-6::gfp expression, and there is a
decrease in the mitochondrial proton gradient in the RNAi
animals. The fact that down-regulation of several mitochondrial
ribosomal protein genes produce the same phenotype implies that
this effect is likely to be observed for many components of the
mitochondrial ribosome.
RNAi against mrps-2, mrps-10 and mrpl-43 induced the
formation of complete dauers (the Daf-c phenotype) under
conditions that normally prevent this from happening. For the
Daf-c phenotype, the RNAi treatments were synergistic with a
weak mutation in a TGFb pathway component but not with a
weak mutation in the IIS pathway (Figure 3E), suggesting that the
phenotype is caused specifically by reduction in IIS pathway
activity. This conclusion is supported by the fact that larval growth
arrest was daf-16 dependent and that DAF-28::GFP secretion was
low. One attractive explanation for low IIS activity is that the
inhibition of ribosomal activity leads to defects in oxidative
phosphorylation and redox balance [40] as evidenced by the
weaker TMRE staining (Figure 4B). This is important for the
mitochondrial ATP/ADP ratio which, when it is high promotes
insulin secretion. The findings here are consistent with the energy
sensor hypothesis that proposes that defects in energy levels
produce specific developmental defects [41] and [42]. However,
the demonstration that alteration of mitochondrial activity in one
tissue can have an effect in a distant tissue [43] makes it difficult to
say whether the observed effect was due to perturbation of
mitochondrial activity directly in the DAF-28 secreting cells.
We have previously shown that the onset of mitochondrial
dysfunction by inactivation of tomm-40 causes reduced DAF-
28::GFP secretion and consequently weaker IIS signaling. The
effect of tomm-40(RNAi) on IIS strength could be reversed by over-
expressing daf-28. [21]. The analysis of misc-1also shows the
involvement of mitochondrial function in DAF-28 secretion. [44].
The findings presented here reinforce the conclusions from these
previous studies that mitochondrial activity is important for insulin
secretion and IIS activity likely because of its effect on metabolic
activity. This is in keeping with the observations in mouse models
and human patients that mitochondrial activity is important for
insulin secretion and the diabetic phenotype.
The work presented here emphasizes the role of the
mitochondria and the Golgi apparatus in the maintenance of IIS
activity. Since the genes identified here are conserved throughout
evolution, it is likely that their orthologs will modulate IIS levels in
other animals.
Supporting Information
Figure S1 Accumulation of DAF-28:GFP in gonadal
sheath cells. Paired DIC (left) and fluorescence (right) images
of a daf-28::gfp; ykt-6(RNAi) animal showing accumulation of GFP
in a honeycomb pattern characteristic of gonadal sheath cells. The
DIC image shows that the plane of focus is at the surface of the
gonad.
(TIF)
Figure S2 GST-4::GFP is not up-regulated in the
mitochondrial dysfunction mutants. Fluorescence micro-
graphs of RNAi-treated animals expressing the oxidative stress
marker Pgst-4::GFP::NLS. Five animals are displayed in each
panel.
(TIF)
Table S1 List of genes which are predicted or proven
interactors of C.elegans asna-1 or its orthologs in
S.cerevisiae and D.melanogaster. The Feeding RNAi screen
for the 86 C. elegans homologs of total 143 was carried out and
following phenotypes are listed in the last column. Wt: Wildtype;
Lva: larval arrest; Sck: Sick; Prl: paralysed Let: lethal; Emb:
Embryonic Lethal; Gro: Slow growing; Ste: Sterile.
(DOC)
Table S2 Mitoprot analysis of putative C. elegans
mitochondrial ribosomal proteins.
(DOC)
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